However, we observed that the expression pattern of both genes was consistent in tumor tissues of gynecological cancers (i.e., Uterine Carcinosarcoma [UCS] and Uterine Corpus Endometrial Carcinoma [UCEC]) compared with tumor-adjacent controls, and this difference was more noticeable for CTLA4 (Figure 1A). The gene discussed is CTLA4; the disease is neoplasm.